Skip to main content
. Author manuscript; available in PMC: 2010 Jan 1.
Published in final edited form as: J Gen Virol. 2009 Jan;90(Pt 1):115–126. doi: 10.1099/vir.0.004408-0

Table 1.

Inhibition of HBsAg secretion in HepG2 cells by shRNA

Relative HBsAg in culture medium (%)*
Sample Day 1 (P.T. HBV) Day 2 (P.T. HBV) Day 4 (P.T. HBV)
U6S 1.13 ± 0.92 0.39 ± 0.26 0.28 ± 0.37
U6Control 100 ± 6.43 100 ± 6.13 100 ± 1.68
Mock 112.35 ± 15.43 89.74 ± 10.39 78.74 ± 15.95
*

Data represents mean ± SEM standardized to U6Control treated samples of three independent experiments performed in duplicate.

Statistical differences between U6S and U6Control were tested using Student’s t-test, P≤ 0.005.